
SynBioBeta 2026 Speaker
Ivan Jayapurna
ARIA
Programme Director
Running a ยฃ50m programme to turn proteins into โUniversal Fabricatorsโ. Today most protein engineers design drugs and enzymes. If successful, programmable proteins (+ reactor flows/fields) will assemble next-gen inorganic and composite materials for electronics, energy, and infrastructure that currently cannot be mass manufactured.



Reagan
Jarvis
Anocca AB
CEO, Co-founder

Alex
Rives
CZI Biohub
Head of Science

Karenโฏ
Akinsanya
Schrodinger
President, R&D โ Therapeutics

Christopher
Arendt
Takeda
CSO, Head of Research

Stef
van Grieken
Cradle
CEO

Michael
Koeris
DARPA
Director, BTO

Jennifer
Dionne
Pumpkinseed
CEO

Daniyal
Hussain
GSK
Exec. Dir., Tech BD

Cynthia
Hong
Novartis
Dir., Search & Evaluation
SynBioBeta 2027 May 3-6, San Jose, California


